Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Sandusky, OH
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Sandusky, OH
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Toledo, OH
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Toledo, OH
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Westlake, OH
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Westlake, OH
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Oklahoma City, OK
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Portland, OR
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Portland, OR
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Beaver, PA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Beaver, PA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Danville, PA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Danville, PA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Doylestown, PA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Doylestown, PA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Erie, PA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Erie, PA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Jersey Shore, PA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Jersey Shore, PA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Lewistown, PA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Lewistown, PA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Philipsburg, PA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Philipsburg, PA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Pittsburgh, PA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Port Matilda, PA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Port Matilda, PA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Sayre, PA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Sayre, PA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Scranton, PA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Scranton, PA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Sellersville, PA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Sellersville, PA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Wilkes-Barre, PA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Wilkes-Barre, PA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
York, PA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
York, PA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Spartanburg, SC
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Spartanburg, SC
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Rapid City, SD
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Rapid City, SD
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Sioux Falls, SD
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Bristol, TN
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Bristol, TN
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Johnson City, TN
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Johnson City, TN
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Amarillo, TX
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Amarillo, TX
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Corpus Christi/Texas, TX
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Corpus Christi/Texas, TX
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Dallas, TX
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Georgetown, TX
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Georgetown, TX
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Harker Heights, TX
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Harker Heights, TX
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Houston, TX
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Plano, TX
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Plano, TX
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
San Antonio, TX
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Victoria, TX
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Victoria, TX
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Draper, UT
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Draper, UT
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Burke, VA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Burke, VA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Norfolk, VA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Norfolk, VA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Winchester, VA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Winchester, VA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Kirkland, WA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Kirkland, WA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Olympia, WA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Olympia, WA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Renton, WA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Renton, WA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Seattle, WA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Seattle, WA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Spokane, WA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Spokane, WA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Tacoma, WA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Tacoma, WA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Walla Walla, WA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Walla Walla, WA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Wenatchee, WA
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Wenatchee, WA
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Wausau, WI
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Wausau, WI
Click here to add this to my saved trials
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated:  7/9/2015
GSK Investigational Site
mi
from
Adrogue,
The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)
Status: Enrolling
Updated: 7/9/2015
GSK Investigational Site
mi
from
Adrogue,
Click here to add this to my saved trials
Randomized Trial Evaluating Performance of the Trevo Retriever Versus the Merci Retriever in Acute Ischemic Stroke
Thrombectomy REvascularization of Large Vessel Occlusions in Acute Ischemic Stroke (TREVO 2)
Status: Enrolling
Updated:  7/13/2015
Oregon Health and Sciences University
mi
from
Portland, OR
Randomized Trial Evaluating Performance of the Trevo Retriever Versus the Merci Retriever in Acute Ischemic Stroke
Thrombectomy REvascularization of Large Vessel Occlusions in Acute Ischemic Stroke (TREVO 2)
Status: Enrolling
Updated: 7/13/2015
Oregon Health and Sciences University
mi
from
Portland, OR
Click here to add this to my saved trials
Intravenous Immunoglobulin for Early Prevention of Cardiopulmonary Bypass Induced Hypogammaglobulinemia in Infants and Neonates
Status: Enrolling
Updated:  7/14/2015
Children's of Alabama
mi
from
Birmingham, AL
Intravenous Immunoglobulin for Early Prevention of Cardiopulmonary Bypass Induced Hypogammaglobulinemia in Infants and Neonates
Status: Enrolling
Updated: 7/14/2015
Children's of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Pilot Evaluation of the JHI Platform
Pilot Evaluation of the Janssen Healthcare Innovation Integrated Cardiovascular Rehabilitation Management Platform (JHI PLATFORM).
Status: Enrolling
Updated:  7/15/2015
Henry Ford Hospital
mi
from
Detroit, MI
Pilot Evaluation of the JHI Platform
Pilot Evaluation of the Janssen Healthcare Innovation Integrated Cardiovascular Rehabilitation Management Platform (JHI PLATFORM).
Status: Enrolling
Updated: 7/15/2015
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials